TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.44 -0.1 (-23.33%) 0.0 (-0.01%) 0.0 (0.06%) 0.0 (-0.62%) -0.04 (-9.48%) -0.07 (-16.93%) 0.0 (1.48%) 0.0 (1.48%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.1735
Diluted P/E:
-0.1735
RSI(14) 1m:
91.86
VWAP:
0.33
RVol:

Events

Period Kind Movement Occurred At

Related News